Klinické Centrum ISCARE
    Hospital
    
    
        Location: 
        Prague,
        
                Czech Republic (CZ)
                
    
 
        
    
    
        ISNI: 0000000406095004
    
    
        ROR: https://ror.org/01teb0938
    
    
    
    
    
        
    
        
    
        
    
    
    
        
            
                
  
  Comparative efficacy and safety of subcutaneous infliximab and vedolizumab in patients with Crohn’s disease and ulcerative colitis included in randomised controlled trials (2024)
  Peyrin‐Biroulet L, Arkkila P, Armuzzi A, Danese S, Ferrante M, Jordi Guardiola , Jahnsen J, et al.
  Journal article
            
                
  
  Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease: a systematic review and meta-analysis (2022)
  Peyrin-Biroulet L, Arkkila P, Armuzzi A, Danese S, Guardiola J, Jahnsen J, Lees C, et al.
  Journal article, Review article
            
                
  
  A comparative efficacy and safety analysis of subcutaneous infliximab and vedolizumab in patients with Crohn's Disease and Ulcerative Colitis (2022)
  Peyrin-Biroulet L, Arkkila P, Armuzzi A, Atreya R, Danese S, Ferrante M, Guardiola J, et al.
  Conference contribution